Abstract
Macrophage tumoricidal activity relies, mainly, on the release of Tumor Necrosis Factor alpha (TNFα) and/or on reactive oxygen or nitrogen intermediates. In the present work, we investigated the cytotoxic activity of resident peritoneal macrophages against L929 fibrosarcoma cell line in vitro and in vivo. Resident macrophages lysed L929 cells in a mechanism independent of TNFα and cell-to-cell contact. The cytotoxic activity was largely dependent on nitric oxide (NO) release since treatment with L-NAME (NOS inhibitor) inhibited L929 cells killing. Macrophages from mice with targeted deletion of inducible NO synthase (iNOS) together with L929 cells produced less NO and displayed lower, but still significant, tumoricidal activity. Notably, NO production and tumor lysis were abolished in co-cultures with macrophages deficient in Interferon Regulatory Factor, IRF-1. Importantly, the in vitro findings were reproduced in vivo as IRF-1 deficient animals inoculated i.p with L929 cells were extremely susceptible to tumor growth and their macrophages did not produce NO, while WT mice killed L929 tumor cells and their macrophages produced high levels of NO. Our results indicate that IRF-1 is a master regulator of bi-directional interaction between macrophages and tumor cells. Overall, IRF-1 was essential for NO production by co-cultures and macrophage tumoricidal activity in vitro as well as for the control of tumor growth in vivo.
Introduction
Activated macrophages are endowed with antitumor activities that in part are dependent on nitric oxide (NO) production [1]. Inducible NO synthase (iNOS or NOS2) is one of the enzymes that catalyses the conversion of arginine to NO and citruline. NO produced in such reactions has a role in diverse biological processes, including microbicidal activities, regulation of inflammatory and immune processes and control of tumor growth [2]. Bi-directional interactions between macrophages and tumor cells with stimulatory or inhibitory activities on NO production have been reported [3]. For instance, some tumors such as fibrosarcomas induce NO production in murine and human macrophages, whereas other tumors such as advanced melanoma or cervical cancer suppress NO production [4,5,6].
Interferons (IFNs) are key elements in iNOS expression regulation [6,7]. It is known that IFNs signaling is initiated by two distinct cell-surface receptors, type I IFN receptor (IFNAR) and the type II IFN receptor (IFNGR) [7]. Signaling through IFNAR/STAT1 leads to the formation IFNα-activated factor that mediates the activation of interferon regulatory factor 1 (IRF-1) gene by binding to IFNγ-activated sequence (GAS) in IRF-1 promoter [8]. Similarly, type II IFN signaling through IFNGR/STAT1 also results STAT1 homodimers binding to GAS and IRF-1 gene transcription [9]. IRF-1 is the first described member of the family transcription factors known as Interferon Responsive Factors [10], which have fundamental roles in responses against intracellular pathogens, including induction of iNOS and consequent NO production. IRF-1 binds to the IFN regulatory factor element (IRF-E) present in the iNOS promoter, and together with NFκB, C/EBP and STAT1, activate its transcription [11]. Using a knockout mouse model, Kamijo and colaborators showed that IRF-1 activity is essential for iNOS expression in mice [12]. Thus, IRF1 seems to be at the crossroad of type I and type II IFN signaling for NO production [12,13].
L929 murine fibrosarcoma cell line treated with Actinomycin D (ActD), a transcription inhibitor, becomes extremely susceptible to TNFα induced cytotoxicity [14,15], where TNFα treatment promotes ROS production prior to cell death [16]. However, in absence of ActD, treatment with IL-1β and IFNγ induces cytotoxicity in L929 cells, via the p38/NFκB/iNOS/NO pathway [17]. In this case, IRF-1 is an element of convergence of these pathways, once, as described before, it is central for IFN signalling, but also may be expressed upon p65 NFκB binding to its promoter. Therefore, IRF-1 links different pathways in the cells that may culminate with iNOS expression and NO production. We have previously shown that in the absence of ActD, L929 fibrosarcoma cells became sensitive to lysis by activated macrophages in an NO dependent and TNFα independent mechanism [18]. Other studies reported that cytokine or LPS activated macrophages when co-cultured with L929 cells produce high concentrations of NO [19,3] and induced tumor cell lysis in a cell-to-cell contact dependent mechanism [20,21,22]. Moreover, cisplatin treated macrophages co-cultured with L929 cells produced NO that mediated L929 cell death [23].
Most studies, including ours, showed NO dependent L929 tumoricidal activity using in vitro or ex vivo activated or stimulated macrophages. However, few studies focused on the interaction between L929 tumor cells and resident macrophages without artificial activation, a situation that is likely to occur in vivo upon the development of tumors. In the present work, we investigated the interaction of peritoneal resident macrophages with L929 cells in vitro. Moreover, we determined the host’s immune-molecular mechanisms that were triggered after in vivo injection of L929 tumor cells. We used macrophages obtained from mouse strains that are deficient in key regulatory molecules involved in IFN signaling or in iNOS expression. Specifically, we determined whether MyD88, iNOS and IRF-1 were relevant molecules for the control of tumor cell growth in vitro and in vivo. Our results showed that IRF-1 is a master regulator of bi-directional interaction between macrophages and tumor cells. IRF-1 was required for NO induction, macrophage tumoricidal activity in vitro and for the control of tumor growth in vivo.
Material and Methods
1. Mice
Six to twelve-week-old C3H/HePas, C57BL/6, 129/SV, iNOS-/-, MyD88-/-, and IRF-1-/- female mice were bred in our animal facilities at the University of São Paulo, under standard pathogen-free conditions. iNOS-/- mice were originally from Jackson Laboratories (Bar Harbor, ME), MyD88-/- [24] mice were kindly provided by Dr. Bernard Ryffel (Centre National de la Recherche Scientifique, Orléans, France), and IRF1-/-[25] mice were kindly provided by Dr. Luiz Fernando Reis (Hospital Sirio Libanês, São Paulo, Brazil). All procedures described were reviewed and approved by the Animal Ethics Committee of the Institute of Biomedical Sciences, University of Sao Paulo, in accordance with COBEA (Brazilian College of Animal Experimentation), protocol 151/2011.
2. Media and reagents
RPMI 1640 culture medium was supplemented with 10 mM HEPES, 11 mM sodium bicarbonate, 2 mM L-glutamine, 100 μg/mL penicillin, 100g/mL streptomycin, 23 mM L-asparagine, 1 mM folic acid, 0.1 mM pyruvic acid and 5% fetal calf serum. This medium will be referred to as complete medium and was used to maintain all the cell cultures. All these reagents were purchased from Sigma Chemical Co., St Louis, MO, including trypsin, N-nitro-L-arginine methyl ester (L-NAME), actinomycin D (ActD), paraformaldehyde (PFA), bovine serum albumin (BSA), sodium nitrite, sulphanilamide, naphthylene diamine dihydrocloride and glycine. Rabbit polyclonal antibodies against murine TNFα and recombinant interferon-γ(IFNγ) were purchased from Endogen, Boston, MA. Sodium nitroprusside (SNP) was purchased from Riedel-DE Haen AG, Seelze-Hanover (Germany). APC (Allophycocyanin) conjugated and biotin conjugated anti-mouse CD45, clone 30-F11, and FcBlock (anti-CD16/CD32) were purchased from BD Biosciences (San Jose, CA). Biotin blocking kit, immunohistochemistry detection kit ready to use VECTASTAIN Elite ABC Reagent, 3–3’diaminobenzidine peroxidase detection reagent and Harry’s hematoxylin were purchased from Vector Laboratories (Burlingame, CA). DAF-2, 4, 5-diaminofluorescein diacetate, was purchased from Enzo Life Sciences (Farmingdale, NY).
3. Peritoneal cells harvesting
Mouse peritoneal cells were harvested by washing the peritoneal cavity with 5 mL sterile ice-cold PBS. Total cell numbers were estimated by counting cells in hemocytometer. Differential cell counts were determined by cytospin preparations stained with Instant-Prov (Newprov, Pinhais, Brazil).
4. L929 cell cultures and treatments
L929 fibrosarcoma cell line was originally obtained from the American Type Culture Collection (Rockville, Maryland, USA) and has been maintained in our laboratory in 10% fetal bovine serum RPMI 1640 medium at 37°C in humidified air containing 5% CO2.
L929 supernatant (L929 sup) was obtained from 48 hours cell cultures (1x106/mL). After harvesting, supernatants were filtrated through 0.22 μm Millipore membrane and used in macrophage cultures diluted 1:1 (v/v) in RPMI medium.
To evaluate the direct cytotoxic effect of NO in L929 cells, the sodium nitruprusside (SNP), an NO donor, was added to L929 cells culture at a 10–1, 10–2, 10–3 and 10–4 M concentration for 48 h.
For co-culture experiments, adherent L929 cells were detached by trypsin solution treatment (0.4 g Trypsin, 8.0 g NaCL, 0.4 g KCL, 1.0 g Glucose, 0.350 g NaHCO3, 0.2 g EDTA in 1L H2O), replenished with 10 mL of complete medium and centrifuged once (150 g, 10 min, 4°C). Cell viability determined by Trypan Blue exclusion. Cells were seeded in 96-well flat-bottom microplates, 3.5x104 cells/well, and incubated for 24 h until obtaining a monolayer.
5. Macrophage/L929 cells co-cultures
We first seeded 3.5x104 L929 cells/well on flat bottom 96 wells plates and incubated them for 24 hours to generate monolayers. Resident peritoneal cells were harvested with sterile ice-cold PBS, counted and adjusted to 2x106 cells/ml. These cells seeded over the L929 monolayers at a final density of 2x105 cells/well (as indicated in the figure legends) and incubated for 48 hours. At the end of this period, we harvested supernatants for Griess assay, while cells were fixed and stained with Crystal Violet as described bellow. To confirm that macrophages were the agents of the effects we were observing, we also used adherent peritoneal cells from individual mice, which were detached, washed and seeded over L929 monolayers at a density of 5x104 cells/well. No differences were obtained between co-cultures with total peritoneal cells and adherent peritoneal cells. In this work we will show only data regarding the total peritoneal suspension and for the sake of simplicity, heretofore we will address resident peritoneal cells as peritoneal macrophages.
In some experiments, before the macrophage addition to the plates, L929 cells were fixed with 1% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) for 25 min at room temperature, followed by washing with PBS containing 1% glycin and 1% bovine serum albumin (BSA) for 30 min at 37°C. In another set of experiments, L929 cells were treated with 2 μg/mL ActD at 37°C for 1 hour, when the wells were carefully washed two times with RPMI medium.
6. Treatments in the co-cultures
Rabbit polyclonal antibodies to murine TNFα (20μg/mL), L-NAME (2.5, 5.0 or 10mM) and aminoguanidine (0.1 to 100 mM) were added to co-cultures of murine macrophages with L929 and were maintained throughout each experiment (48 h). Mouse recombinant IFNγ was added to the co-cultures with macrophages from IRF-1 knockouts at 2.5, 5.0 and 10 μg/mL.
7. Transwell assays
In some experiments, macrophages were cultured by 48 h separated from L929 cells by a cell-impermeable membrane (Transwell culture, Costar, 0.4 μm pore size).
8. Detection of NO production
The NO production was quantified by the accumulation of nitrite (as a stable end product) in the supernatants by the Griess reaction. Briefly, 50μL of supernatants were incubated with an equal volume of Griess reagent at room temperature for 10 min. The absorbance at 550nm was determined on a Dynatech microplate reader. Nitrite concentration was determined from a sodium nitrite standard curve.
Alternatively, to demonstrate that the macrophage and L929 cells were producing NO we used the NO-sensitive dye, 4, 5-diaminofluorescein diacetate (DAF-2) [26]. Adherent cells were incubated at 37°C with 12.5 μM DAF-2 in 0.1 M phosphate buffer (pH 7.4) containing 0.45 μM CaCl2. After 2 h, digital images were acquired on a Nikon E1000 microscope equipped for epifluorescence (excitation at 485 nm; emission 538 nm). The images were analyzed using the Image software (NIH, USA) by measuring the mean optical density of the fluorescence observed in the cells in relation to the background staining.
9. Cytotoxicity assay
L929 cell death was determined by the crystal violet staining method. After 48 h of co-culture, L929 cells were stained by adding 10 μL of a solution containing 0.5% crystal violet and 30% acetic acid to the remaining 50 μL of cell medium culture for 10 minutes. Excess stain was removed under a tap water rinse, and the plate was air-dried. A volume of 100 μL of absolute methanol was added to dissolve the stain and the absorbance was determined at 630 nm on a Dynatech microplate reader. The macrophage cytolitic activity was expressed as the percentage of tumor cytotoxicity where % cytotoxicity = (1- O.D. of L929 cells co-cultured with macrophages/ O.D. of control L929 cells) x100. Importantly, 2x105 peritoneal macrophages cultured for 72 hours resulted in staining correspondent to 27% of the L929 monolayers, while co-cultures resulted in 10% due to cell death. This result indicates that macrophages are washed away before staining and do not interfere in the L929 cell viability assay (S1a Fig.)
10. L929 tumor cell inoculation in mice peritoneal cavity
L929 tumor cells (5x105/mouse, in 100 μL sterile PBS) were inoculated intraperitoneally in mice. Cells were harvested seven days later as previously described.
11. Flow cytometry analysis
Aliquots of 106 cells from the peritoneal cavity were transferred to 1X Hank’s Salt Solution supplemented with 15 mM HEPES pH 7.4, 5% fetal bovine serum, 0.5 U/ml DNase I. After blocking with FcBlock (antiCD16/CD32, BD Biosciences, San Jose, CA), cells were incubated with APC conjugated anti-CD45 for 20 min and washed (BD Biosciences, San Jose, CA). Cell samples were analyzed in a FACSCalibur, where we used the FL2 channel to determine cells autofluorescence and FL4 to detect cells stained with anti-CD45. We determined the absolute numbers of L929 cells in the peritoneal cavity of each mouse by multiplying the percentage of CD45- cells in each sample by the total number of cells in the peritoneal lavage.
12. Immunocytochemistry
Aliquots of 4x104 peritoneal cells were fixed to a glass slide using a cytospin centrifuge. Cells were hydrated (3 PBS washes), endogenous peroxidase activity quenched with 0.3% H2O2 and endogenous biotin blocked with Biotin Block kit reagents (Vector Laboratories, Burlingame, CA), prior to non specific antigen blocking with 5% fetal bovine serum and 0.05 μg/mL FcBlock (anti-CD16/CD32, BD Biosciences, San Jose, CA) in PBS for 30 minutes. After aspirating the blocking solution, cells were incubated with biotinylated anti-CD45 diluted in 5% fetal bovine serum in PBS for one hour at room temperature. After washing, we incubated the cells with ready-to-use stabilized ABC reagent for 30 min, at room temperature. Antibody complex detection was made with 3’3-Diaminobenzidine (Vector Laboratories, Burlingame, CA). Cells were counterstained with Harris Hematoxylin (Vector Laboratories, Burlingame, CA) and mounted with Permount (Fisher Scientific, Loughborough, UK). Images were acquired with an Olympus BX61 fluorescence microscope (Olympus, Center Valley, PA). Number of L929 cells was estimated by multiplying the percentage of CD45- by the total number of cells in the peritoneal lavage.
13. Statistical analysis
All experiments were performed at least three times and one representative experiment is presented. Differences between experimental groups were tested for significance through the Student’s t-test, where p<0,05 indicated statistically significant results.
Results
1. L929 cell lysis is dependent on NO production
In co-cultures of L929 fibrosarcoma cells with resident macrophages we found a significant NO production in 24h, which increased further upon 48 to 72h of culture. Paralleling NO production, we observed cytotoxicity against L929 cells (Fig. 1a). Resident macrophages or L929 cells cultured alone did not release NO (data not shown). To establish the role of NO in L929 cells lysis, we treated cultures with sodium nitroprusside (SNP), a NO donor, or L-NAME, a nitric oxide synthase (NOS) inhibitor at increasing concentrations [27]. Treatment with SNP treatment increased NO release and L929 cell lysis in a dose-dependent manner (Fig. 1b). Conversely, L-NAME inhibited NO production and L929 cell lysis in a dose-dependent manner (Fig. 1c).
Importantly, resident macrophages as well as L929 cells cultured alone did not produce detectable levels of NO (S1b Fig.), indicating that resident macrophages are not activated, confirming previous work from our laboratory, where we compared resident and BCG activated macrophages [28].
2. L929 cell lysis and NO production are independent of cell-to-cell contact
To determine whether cell-to-cell contact is required for NO production and tumor cytotoxicity we established co-cultures using a transwell system that separated L929 cells from resident macrophages by a cell-impermeable membrane. We found that cell-to-cell contact was dispensable for NO production and L929 cell lysis as these events persisted in transwell cultures (Fig. 2a). These results indicated that the cross talk between macrophages and tumor cells was mediated by soluble factor(s). Indeed, addition of L929 supernatant to resident macrophage cultures significantly induced NO production (Fig. 2b). This mechanism was largely dependent on RNA transcription and viable L929 cells, as ActD treatment inhibited this effect and treatment with paraformaldehyde (PFA) completely abolished the effect of L929 supernatant on macrophages (Fig. 2c). Based on these data, we concluded that L929 cells induction of NO production in macrophages was contact independent and exerted by soluble factors that required mRNA transcription.
3. TNFα is not involved in L929 cell lysis by macrophages
ActD treated L929 cells became extremely susceptible to TNFα and as such it is used as a biological test to measure TNFα activity [29,30]. Indeed, the susceptibility of L929 cells to TNFα only became apparent when L929 cells were treated with ActD (Fig. 3a). Interestingly, at high concentration of TNFα, L929 cells (not treated with ActD) produced low levels of NO as revealed by Griess reagent and DAF staining, indicating that L929 cells are able to produce NO (Fig. 3b). However, at these concentrations of NO there was no change in L929 cell viability (Fig. 3a, 3c). Having established that in our conditions TNFα do not induce L929 lysis, we investigated whether TNFα is involved in tumoricidal activity in our co-cultures of L929 cells and murine macrophages using anti-TNFα antibodies. Blocking TNFα with a neutralizing antibody had no effect on NO production or L929 cell lysis (Fig. 1d).
4. iNOS activity is important for maximal NO production in co-cultures of L929 cells and macrophages
High concentrations of NO are produced upon activation of iNOS [31]. Therefore; we determined the role of iNOS in NO production and L929 cell lysis, using iNOS-deficient macrophages. We found a significant reduction in NO concentration and DAF staining of co-cultures of iNOS KO macrophages with L929 cells compared to co-cultures with control wild type (WT) macrophages (Fig. 4a-e). As expected, L929 cells lysis also decreased (Fig. 4a). Notably, although NO production was decreased in co-cultures with iNOS-deficient macrophages as revealed by Griess reaction and DAF staining, it was not abolished (Fig. 4a, 4e); suggesting that residual NO production was probably derived from L929 cells. These results suggest that macrophages and L929 cells stimulate each other for NO production and in the absence of iNOS expression in macrophages, there is still residual NO production by L929 cells.
5. IRF-1 but not MyD88 adaptor molecule is essential for NO production by macrophage-L929 cells co-cultures
Since it was shown that IRF-1 activity is essential for iNOS expression in mice [12] and that MyD88 molecule, an important adaptor molecule in Toll-Interleukin-1 receptor signalling, also participate in the induction of NO production [6] we used co-cultures of L929 cells with IRF-1 or MyD88 deficient macrophages. MyD88 deficiency did not influence NO production (Fig. 5a) or L929 cell lysis (Fig. 5b). In contrast, IRF-1 was essential for NO production and L929 cell lysis (Fig. 5a-b). These results suggest that the crosstalk between macrophage and L929 cells is essential for these cells to produce NO and entirely dependent on macrophage IRF-1. Since IRF-1 is one of the targets of IFNγ signalling [9] we treated macrophage/L929 co-cultures with IFNγ to induce NO production. Indeed IFNγ induced NO production in a dose dependent manner in co-cultures of L929 cells with WT macrophages. However, NO production was completely abolished in co-cultures with IRF-1 deficient macrophages (Fig. 6).
6. Induction NO production by peritoneal macrophages from mice inoculated with L929 cells
Concluding that L929 cells induce NO production by macrophages in vitro, we next tested if this phenomenon would also occur in vivo. We inoculated different concentrations of L929 cells in C57BL/6 mice peritoneal cavities and harvested cells 7 days later. We observed that NO production by peritoneal macrophages increased in direct proportion with the number of L929 cells inoculated in the peritoneal cavity (Fig. 7a). Therefore, L929 cells could stimulate peritoneal macrophages in vivo for NO production.
7. In vivo NO production and L929 cell lysis is dependent on IRF-1 expression
After determining that L929 inoculated in the peritoneal cavity could stimulate resident macrophages, we aimed to determine the molecular mechanism responsible for this effect. We inoculated L929 cells in the peritoneal cavity of MyD88, iNOS, and IRF-1 deficient mice and 7 days later, harvested peritoneal cells to quantify NO production. As expected, MyD88 deficiency had no effect on NO production, these cells even showed an increase in NO concentration in their supernatant. In cells from iNOS deficient mice, we observed a decrease in NO production, indicating the iNOS contribute, but it is not critical for NO production. However, as observed before, IRF-1 was essential for NO production, since NO production was completely abolished in cells from IRF-1 deficient mice (Fig. 7b). Next, we quantified L929 cell growth by total and differential cell counts using morphologic criteria, which in the case of L929 cells was the size (larger than leukocytes), cytoplasm/nuclei ratio (higher than in leukocytes) and mitosis figures. We found that the total number of cells harvested from the peritoneal cavity of these mice 7 days after inoculation was significantly higher in iNOS deficient mice and even higher in IRF-1 deficient mice when compared with wild type (WT) or MyD88 deficient mice (Fig. 7c). Increase in L929 cell numbers was similar to the pattern observed for the total number of cells (Fig. 7d). We further confirmed these results by staining peritoneal total cell suspensions with anti-CD45 antibody and estimated the number of negatively stained cells, correspondent to L929 cells, either by immunohistochemistry (Fig. 7e-f) or by flow cytometry (S2 Fig.). We not only observed an increase in L929 cells in iNOS and IRF-1 deficient mice, we could also see L929 dividing cells in the peritoneal cavity of IRF-1 deficient mice, indicating that these mice could not control L929 cells growth.
Discussion
The main finding of the present work indicates that resident macrophages co-cultured with L929 tumor cells, without addition of any exogenous cytokine, are able to produce NO and kill L929 tumor cells in a NO dependent- cell contact-independent manner. Indeed, we found that resident macrophages incubated with conditioned medium of L929 cells produced NO. However, PFA-fixed L929 cells did not stimulate NO production indicating that viable L929 tumor cells are required for NO production. By comparing our findings with previous reports we want to highlight some important differences. First, we found that exogenous stimulants were not required for NO production while other reports showed that NO production is only observed after addition of IFNγ or IFNγ plus TNFα to co-cultures of RAW 264.7 macrophages with L929 cells [19]. Similarly, Zembala and collaborators [32] showed that human monocytes produced NO in co-cultures with L929 cells only in the presence of exogenous cytokines while we found a significant NO production in co-cultures of resident macrophages with L929 cells. Second, Isobe and Nakashima and Nozaki and collaborators demonstrated an essential role of cell-to-cell contact for NO production while in our model cell-to-cell contact was not important [21,22]. Third, Calorini and collaborators described that L929 fibrosarcoma stimulated NO secretion only in co-cultures with inflammatory macrophages but not with resident macrophages [3]. Finally, there is data showing that activated macrophages could lyse L929 cells in a TNFα dependent, NO independent mechanism [33,34]. It is important to note that in these experiments the period of incubation of co-cultures was 18 hours, and at that time we could not detect significant L929 lyses that only occurred after 24 hours of co-cultures.
Our evidence of a cytotoxic mechanism dependent on NO production comes from the experiments where we inhibited NO production or generated NO in the medium through a donor. In contrast, we could not reveal a role for TNFα involvement since blocking of TNFα with neutralizing antibody had no effect on L929 lysis, either using mouse resident macrophages. The differences between our results and those reported above are still elusive, but might be related to the L929 cell line, macrophage source and handling and different protocols used. However, our L929 cell line when treated with ActD became extremely sensitive to TNFα-mediated cytotoxicity that was blocked by anti-TNFα treatment confirming previous reports about this cell line [35,36].
TNFα and NO, as well as other mediators secreted by tumor inflammatory infiltrate, mainly macrophages and myeloid cells, have been reported to exert contrasting effects on tumor cells. Cytotoxic effects of TNFα and NO on tumor cells are well established [37,34,38]. However, chronic inflammatory signalling can stimulate tumor progression through the inhibition of T cell activity via NO, alteration in tumor cell signalling and accumulation of mutations [39,40,41,42]. Some tumor cells also generate inflammatory mediators, resulting in a complex tumor microenvironment that is fundamental for determining tumor fate [43,44].
In line with our observations with TNFα treatment and NO production, it was shown that L929 tumor cells treated with a combination of IFNγ and IL-1 displayed a significant increase in NO production and cell death indicating that L929 cells do produce NO that, in turn, depending on the concentration, has an autocrine cytotoxic effect [17]. Interestingly, using macrophages from iNOS deficient mice in the co-cultures with L929 cells, we verified that although low, NO production persisted, suggesting that, in our experimental conditions, L929 cells might also release this metabolite. Indeed, we found that L929 cells positive for a dye that marks NO production (Fig. 3d). The fact that besides producing NO, L929 tumor cells stimulated resident macrophages to produce this metabolite, led us to investigate the molecular mechanisms involved in this cross-activation. L929 cells secrete cytokines as M-CSF, which can induce differentiation of bone marrow cells into macrophages [45]. Neutralizing of M-CSF had no effect on NO production in resident macrophages in co-culture with L929 cells (data not shown). Indeed, M-CSF signals mainly through PI3K and MAPK, possibly without involvement of the IRF-1 pathway. However, L929 cells also secrete type I IFNs that are known to induce iNOS activation in different cell types [46,9]. We tested NO production in co-cultures of L929 cells with resident macrophages from type I and type II IFN receptors. In both cases, we observed a partial reduction of NO production compared to cultures with WT macrophages (data not shown). This result indicates that both type I or II IFNs are involved in NO production. The pathways triggered by these cytokine receptors activate STAT1 and/or STAT2 leading, among other factors, to activation of IRF-1 [47,48,49,50]. IRF-1 was originally identified as a nuclear factor that bound specifically to the IFNβ promoter and its cDNA was subsequently cloned from murine L929 fibroblasts [10]. IRF-1, together with NF-κB and STAT1 transcription factors, may bind to the promoter of iNOS gene, inducing NO production in macrophages. IRF-1 is associated to the IFNs-related mechanism of activation of iNOS in macrophages [11,12,51]. Therefore, our next step was to investigate the participation of theses molecules in the cross talking between these two cell populations.
Tumor cells may generate DAMPs, TLR ligands, activating the TLR/MyD88/NFκB pathway [52]. However, as shown MyD88 deficient macrophages were still able to produce NO and kill L929 cells in co-cultures, thus emphasizing the independence of the MyD88 triggered signalling in NO production and macrophage cytotoxicity. On the other hand, the NO production in the co-cultures of resident macrophages from IRF-1 deficient mice with L929 was totally abrogated in both cell populations. Besides, the addition of IFNγ in the co-culture did not induce detectable amounts of NO when the macrophages were IRF-1 deficient, suggesting that in these conditions, IFNγ by itself was not able to induce NO production neither by resident macrophages nor by L929 tumor cells. These results clearly show that the crosstalk between both cell populations is strictly dependent on IRF-1 and independent on MyD88 molecule in macrophages. Moreover, our results are in line with a report showing that mildly acidic pH inhibited NO production, through inhibition of IRF-1 expression, protecting cells from death [53].
The essential role of IRF-1 and the substantial role of iNOS in macrophage cytotoxic activity lead us to investigate the role of these molecules in tumor growth in vivo. Notably, we found that IRF-1 deficient mice, when inoculated with L929 tumor cells, were not able to produce NO and were extremely susceptible to tumor cells growth when compared with WT mice. We found that the role of iNOS was not as important as IRF-1, since iNOS deficient mice were more susceptible to tumor growth when compared with WT mice, but in comparison with IRF-1 deficient mice iNOS deficient mice were less permissive to tumor growth.
In conclusion, we have clearly shown a cross talk between macrophages and L929 tumor cells, in the absence of any exogenous cytokines, which stimulates murine resident macrophages to produce NO and became cytotoxic by an IRF-1 dependent and contact-independent route (Fig. 8). In addition we showed that type I and type II IFNs are partially involved in the macrophage stimulation by L929 tumor cell. Most importantly, we have shown that the cross-stimulation of L929 tumor cell and resident macrophage is strictly dependent on IRF-1. In the absence of this key molecule the macrophages were unable to produce NO and to kill the tumor cells in vitro and in vivo the mice became extremely permissive to tumor proliferation.
Our work shows a cross-talk between macrophages and L929 cells where IRF-1 and NO production work against tumor cells by inducing L929 cell death in vitro and control of tumor growth in vivo.
Supporting Information
Acknowledgments
We would like to thank Prof. Luiz RG Britto from Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of Sao Paulo for his help with NO detection in L929 cells and co-cultures using the DAF-2 method. This work was supported by grants from Sao Paulo and Maranhão Research Foundations, Conselho Nacional de Desenvolvimento em Pesquisa, Brazil.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
The main funder was from Fundação de Amparo à Pesquisa do Estado de Sao Paulo (FAPESP) grants 2010/20010-2 to APL and 2013/24694-1 to MR. FRFN had a FAPESP doctorate scholarship and support from Universidade Federal do Maranhão (UFMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157: 87–94. [DOI] [PubMed] [Google Scholar]
- 2. Stuehr DJ, Nathan CF (1989) Nitric oxide, a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169: 1543–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Calorini L, Bianchini F, Mannini A, Mugnai G, Ruggieri S (2005) Enhancement of nitric oxide release in mouse inflammatory macrophages co-cultivated with tumor cells of a different origin. Clin Exp Metastasis 22: 413–419. [DOI] [PubMed] [Google Scholar]
- 4. Massi D, Marconi C, Franchi A, Bianchini F, Paglierani M, et al. (2007) Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors. Hum Pathol 38:1516–25 [DOI] [PubMed] [Google Scholar]
- 5. Kobayashi A, Weinberg V, Darragh T, Smith-McCune K (2008) Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunol 1: 412–20. 10.1038/mi.2008.33 [DOI] [PubMed] [Google Scholar]
- 6. Bogdan C (2001) Nitric oxide and the immune response. Nat Immunol 2: 907–16. [DOI] [PubMed] [Google Scholar]
- 7. Trinchieri G (2010) Type I interferon: friend or foe? J Exp Med 207: 2053–2063. 10.1084/jem.20101664 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N (2001) IRF Family of transcription factors as regulators of host defense. Ann Rev Immunol 19: 623–655. [DOI] [PubMed] [Google Scholar]
- 9. Lehtnonen A, Matikainen S, Julkunen I (1997) Interferons up-regulate STAT1, STAT2, and IRF Family transcription fator gene expression. In human peripheral blood mononuclear cells and macrophages. J Immunol 159:794–803. [PubMed] [Google Scholar]
- 10. Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, et al. (1988) Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 54: 903–13. [DOI] [PubMed] [Google Scholar]
- 11. Kröger A, Köster M, Schroeder K, Hauser H, Mueller PP (2002) Activities of IRF-1. J Interferon Cytokine Res 22: 5–14. [DOI] [PubMed] [Google Scholar]
- 12. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, et al. (1994) Requirement for transcription fator IRF-1 in NO synthase induction in macrophages. Science 263:1612–1615. [DOI] [PubMed] [Google Scholar]
- 13. Martin E, Nathan C, Xie Q (1994) Role of Interferon Regulatory Factor 1 in Induction of Nitric Oxide Synthase. J Exp Med 180: 977–984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Humphreys DT, Wilson MR (1999) Modes of l929 cell death induced by TNF-a and other cytotoxic agents. Cytokine 11: 773–782. [DOI] [PubMed] [Google Scholar]
- 15. Vanlangenakker N, Bertrand MJ, Bogaert P, Vandenabeele P, van den Berghe T (2011) TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis 2: e230 10.1038/cddis.2011.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Goossens V, De Vos K, Vercammen D, Steemans M, Vancompernolle K, et al. (1999) Redox regulation of TNF signaling. Biofactors 10: 145–56. [DOI] [PubMed] [Google Scholar]
- 17. Vercammen E, Staal J, Van Den Broeke A, Haegman M, Vereecke L, et al. (2008) Prolonged exposure to IL-1beta and IFNgamma induces necrosis of L929 tumor cells via a p38MAPK/NF-kappaB/NO-dependent mechanism. Oncogene 27: 3780–8. 10.1038/onc.2008.4 [DOI] [PubMed] [Google Scholar]
- 18. Nascimento FRF, Ribeiro-Dias F, Russo M (1998) Cytotoxic activity of BCG-activated macrophages against L929 tumor cells is nitric oxide-dependent. Braz J Med Biol Res 31: 1593–6. [DOI] [PubMed] [Google Scholar]
- 19. Tonetti M, Millo E, Sturla L, Bisso A, De Flora A (1997) Effects of the murine L929 and L1210 cell lines on nitric oxide and TNF-alpha production by RAW 264.7 murine macrophages. Biochem Biophys Res Commun 230: 636–40. [DOI] [PubMed] [Google Scholar]
- 20. Fast DJ, Lynch RC, Leu RW (1992) Nitric oxide production by tumor targets in response to TNF: paradoxical correlation with susceptibility to TNF-mediated cytotoxicity without direct involvement in the cytotoxic mechanism. J Leukoc Biol 52:255–61. [DOI] [PubMed] [Google Scholar]
- 21. Isobe K, Nakashima I (1993) Abundant production of nitric oxide from murine macrophages by direct stimulation of tumor cells. Biochem Biophys Res Commun 192: 499–504. [DOI] [PubMed] [Google Scholar]
- 22. Nozaki Y, Isobe KI, Nakashima I, Shimokata K (1993) Tumor cytotoxicity of nitric oxide produced from alveolar macrophages directly stimulated with tumor cells. Int J Oncol 2:1053–7. [DOI] [PubMed] [Google Scholar]
- 23. Sodhi A, Chauhan P (2007) Interaction between cisplatin treated murine peritoneal macrophages and L929 cells: Involvement of adhesion molecules, cytoskeletons, upregulation of Ca2+ and nitric oxide dependent cytotoxicity. Mol Immunol 44: 2265–2276. [DOI] [PubMed] [Google Scholar]
- 24. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, et al. (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143–50. [DOI] [PubMed] [Google Scholar]
- 25. Reis LF, Ruffner H, Stark G, Aguet M, Weissmann C (1994) Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. EMBO J 13: 4798–806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Kojima H, Nakatsubo N, Kikuchi K, Urano Y, Higuchi T, et al. (1998) Direct evidence of NO production in rat hippocampus and cortex using a new fluorescent indicator: DAF-2 DA . NeuroReport 9: 3345–3348 [DOI] [PubMed] [Google Scholar]
- 27. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142. [PubMed] [Google Scholar]
- 28. Nascimento FRF, Rodríguez D, Gomes E, Fernvik EC, Russo M (2003) A method for multiple sequential analyses of macrophage functions using a small single cell sample. Braz J Med Biol Res, 36: 1221–1226. [DOI] [PubMed] [Google Scholar]
- 29. Flick DA, Gifford GE (1984) Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 68: 167–75. [DOI] [PubMed] [Google Scholar]
- 30. Wright SC1, Kumar P, Tam AW, Shen N, Varma M, et al. (1992) Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem 48: 344–55. [DOI] [PubMed] [Google Scholar]
- 31. Koide M1, Kawahara Y, Tsuda T, Yokoyama M (1993) Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett 318:213–7. [DOI] [PubMed] [Google Scholar]
- 32. Zembala M, Siedlar M, Marcinkiewicz J, Pryjma J (1994) Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolisaccharide. Eur J Immunol 24: 435–9. [DOI] [PubMed] [Google Scholar]
- 33. Cui S, Reihner JS, Mateo RB, Albina JE (1994) Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or-independent mechanisms. Cancer Res 54: 2462–7. [PubMed] [Google Scholar]
- 34. Klostergaard J, Leroux ME, Hung MC (1991) Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro. J Immunol 147: 2802–8. [PubMed] [Google Scholar]
- 35. Shoji Y, Uedono Y, Ishikura H, Takeyama N, Tanaka T (1995) DNA damage induced by tumor necrosis factor-α in L929 cells is mediated by mitochondrial oxygen radical formation. Immunol 84: 543–8. [PMC free article] [PubMed] [Google Scholar]
- 36. Vasil’ev VIU, Krotkova MV, Popova EV, Shatrova AN (1990) The citolytic function of mononuclear phagocytes. II. Factors that determine the binding and lysis of tumor cells by activated macrophages. Tsitologiia 32:275–81. [PubMed] [Google Scholar]
- 37. Darzynkiewicz Z, Williamson B, Carswell EA, Old LJ (1984) Cell cycle-specific effects of tumor necrosis factor. Cancer Res 44: 83–90. [PubMed] [Google Scholar]
- 38. Lorsbach RB, Murphy WJ, Lowenstein CJ, Snyder SH, Russell SW (1993) Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J Biol Chem 268:1908–13. [PubMed] [Google Scholar]
- 39. Raber PL, Thevenot P, Sierra R, Wyczechowska D, Halle D, et al. (2013) Subpopulations of Myeloid-Derived Suppressor Cells (MDSC) impair T cell responses through independent nitric oxide-related pathways. Int J Cancer 134: 2853–64. 10.1002/ijc.28622 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Tazawa H, Kawaguchi T, Kobayashi T, Kuramitsu Y, Wada S, et al. (2013) Chronic inflammation-derived nitric oxide causes conversion of human colonic adenoma cells into adenocarcinoma cells. Exp Cell Res 319: 2835–44. 10.1016/j.yexcr.2013.08.006 [DOI] [PubMed] [Google Scholar]
- 41. Park EJ, Lee JH, Yu GY, He G, Ali SR, et al. (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140: 197–208. 10.1016/j.cell.2009.12.052 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Park YH, Shin HJ, Kim SU, Kim JM, Kim JH, et al. (2013) iNOS promotes HBx-induced hepatocellular carcinoma via upregulation of JNK activation. Biochem Biophys Res Commun 435: 244–9. 10.1016/j.bbrc.2013.04.071 [DOI] [PubMed] [Google Scholar]
- 43. Solinas G, Marchesi F, Garlanda C, Mantovani A, Allavena P (2010) Inflammation-mediated promotion of invasion and metastasis. Cancer Metastasis Rev 29: 243–8. 10.1007/s10555-010-9227-2 [DOI] [PubMed] [Google Scholar]
- 44. Schwartsburd PM (2003) Chronic inflammation as inductor of pro-cancer microenvironment: pathogenesis of dysregulated feedback control. Cancer Metastasis Rev 22: 95–102. [DOI] [PubMed] [Google Scholar]
- 45. Boltz-Nitulescu G, Wiltschke C, Holzinger C, Fellinger A, Scheiner O, et al. (1987) Differentiation of rat bone marrow cells into macrophages under the influence of mouse L929 cell supernatant. J Leukoc Biol 41: 83–91. [DOI] [PubMed] [Google Scholar]
- 46. Hoss-Homfeld A, Zwarthoff EC, Zawatzky R (1989) Cell type specific expression and regulation of murine interferon alpha and beta genes. Virology 173: 539–50. [DOI] [PubMed] [Google Scholar]
- 47. Darnell JE Jr, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415–21. [DOI] [PubMed] [Google Scholar]
- 48. Ihle JN, Kerr IM (1995) Jaks and Stats in signalling by the cytokine receptor superfamily. Trends Genet 11: 69–74. [DOI] [PubMed] [Google Scholar]
- 49. Darnell JE Jr (1998) Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. J Interferon Cytokine Res 18: 549–54. [DOI] [PubMed] [Google Scholar]
- 50. Takaoka A, Yanai H (2006) Interferon signalling network in innate defence. Cell Microbiol 8: 907–22. [DOI] [PubMed] [Google Scholar]
- 51. Nathan C, Xie QW (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915–8. [DOI] [PubMed] [Google Scholar]
- 52. Tsai SY, Segovia JA, Chang TH, Morris IR, Berton MT, et al. (2014) DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLoS Pathog 10: e1003848 10.1371/journal.ppat.1003848 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Harhaji L, Popadic D, Miljkovic D, Cvetkovic I, Isakovic A, et al. (2006) Acidosis affects tumor cell survival through modulation of nitric oxide release. Free Radic Biol Med 40: 226–35. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.